You may have heard of a condition called eosinophilic esophagitis. What do those two words mean? And what do they mean together? "Eosinophilic" refers to a type of white blood cell that is seen in ...

Patients with eosinophilic esophagitis (EoE) often describe the condition as painful, disruptive and frightening.

Eosinophilic Esophagitis (EoE): it's probably the most common allergic reaction you've never heard of. It's a condition that causes the tissues of the esophagus (the tube that connects the mouth to ...

The prevalence of eosinophilic esophagitis is higher among patients with atopic diseases than among those without, a new ...

Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. Sign up (BPT) – Do you find it difficult to swallow food? Does food feel ...

—A team in Japan has identified the ‘caterpillar sign,’ an endoscopic finding that appears to be specific to eosinophilic esophagitis (EoE), and have conducted a study to validate its use as a ...

Eosinophilic esophagitis (EoE) is a newly recognized condition that appears to be increasing in incidence for as yet unknown reasons. It can occur at any age and presents both to gastroenterologists ...

Eosinophilic esophagitis (EoE) is a chronic inflammatory disease driven by a type 2 immune response and characterized by the accumulation of immune cells (eosinophils, basophils, and mast cells) in ...

Mirna Chehade, MD, MPH, discusses eosinophilic esophagitis (EoE), detailing its immune-mediated nature and age-dependent symptoms, emphasizing that in children, symptoms can manifest as feeding ...

The 3 main treatments for EoE are medication, dietary therapy, or mechanical dilation of the esophagus. Patients should be evaluated individually to address their most problematic complaints first, ...

Please provide your email address to receive an email when new articles are posted on . A cohort of patients with atopic disease showed a high rate of gastrointestinal symptoms including food ...

At 12 months, 2/3rds of Cohort 5 patients (48mg dose, 4mg per site) remained in clinical remission after their treatment with ...